BSDGY yields 7.04% · JNJ yields 2.13%● Live data
📍 BSDGY pulled ahead of the other in Year 1
Combined, BSDGY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BSDGY + JNJ for your $10,000?
Bosideng International Holdings Limited researches, designs, develops, manufactures, markets, and distributes branded down apparel products, original equipment manufacturing (OEM) products, and non-down apparel products in the People's Republic of China. The company operates through four segments: Down Apparels, OEM Management, Ladieswear Apparels, and Diversified Apparels. It engages in the business of sourcing and distributing branded down and ladieswear apparels; and non-seasonal apparels, including branded menswear, school uniform, and children's wear. The company provides down apparel products under the Bosideng, Snow Flying, Bengen, etc. brands; ladies wear products under the JESSIE, BUOU BUOU, KOREANO, and KLOVA brands; and school uniforms under the Sameite brand. It also offers network consulting and e-business of down and non-down apparel; logistics and storage services; and brand design and development services, as well as operates as an advertisement agency. As of March 31, 2022, it operated 462 ladieswear retail outlets; 364 self-operated retail outlets; and 98 retail outlets operated by third party distributors. Bosideng International Holdings Limited was founded in 1976 and is based in Central, Hong Kong.
Full BSDGY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.